Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Non Operating Income: 2011-2024

Historic Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Dec 2024 value amounting to $6.5 million.

  • Ptc Therapeutics' Non Operating Income rose 447.33% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 80.13%. This contributed to the annual value of $6.5 million for FY2024, which is 35.40% down from last year.
  • Ptc Therapeutics' Non Operating Income amounted to $6.5 million in FY2024, which was down 35.40% from $10.1 million recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Non Operating Income ranged from a high of $85.2 million in FY2020 and a low of -$57.9 million during FY2021.
  • In the last 3 years, Ptc Therapeutics' Non Operating Income had a median value of $6.5 million in 2024 and averaged -$10.8 million.
  • In the last 5 years, Ptc Therapeutics' Non Operating Income skyrocketed by 520.77% in 2020 and then tumbled by 167.94% in 2021.
  • Yearly analysis of 5 years shows Ptc Therapeutics' Non Operating Income stood at $85.2 million in 2020, then crashed by 167.94% to -$57.9 million in 2021, then grew by 14.98% to -$49.2 million in 2022, then surged by 120.59% to $10.1 million in 2023, then slumped by 35.40% to $6.5 million in 2024.